Jingming Ye

566 total citations
56 papers, 388 citations indexed

About

Jingming Ye is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jingming Ye has authored 56 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cancer Research, 34 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Jingming Ye's work include Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Lesions and Carcinomas (11 papers). Jingming Ye is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Lesions and Carcinomas (11 papers). Jingming Ye collaborates with scholars based in China. Jingming Ye's co-authors include Ling Xu, Xuening Duan, Yinhua Liu, Yinhua Liu, Jianxin Zhao, Shuang Zhang, Qian Liu, Ting Li, Hong Zhang and Bin Zhou and has published in prestigious journals such as Frontiers in Microbiology, The Oncologist and Breast Cancer Research and Treatment.

In The Last Decade

Jingming Ye

51 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingming Ye China	12	205	196	103	90	66	56	388
Antonia Márquez Spain	10	294 1.4×	134 0.7×	71 0.7×	50 0.6×	99 1.5×	15	444
Sara A. Lari United States	10	191 0.9×	275 1.4×	74 0.7×	164 1.8×	52 0.8×	13	414
Douglas M. Minot United States	11	211 1.0×	154 0.8×	45 0.4×	60 0.7×	110 1.7×	14	360
Tomoyuki Aruga Japan	13	230 1.1×	161 0.8×	33 0.3×	91 1.0×	132 2.0×	59	403
Yiwei Tong China	12	169 0.8×	138 0.7×	72 0.7×	42 0.5×	51 0.8×	33	302
Donata Casadei Giunchi Italy	8	182 0.9×	133 0.7×	25 0.2×	74 0.8×	45 0.7×	13	339
Liisa Elomaa Finland	7	215 1.0×	187 1.0×	21 0.2×	67 0.7×	58 0.9×	8	333
Valentina Magri Italy	11	207 1.0×	132 0.7×	56 0.5×	53 0.6×	63 1.0×	28	345
Shaheenah Dawood United Arab Emirates	9	219 1.1×	165 0.8×	21 0.2×	50 0.6×	70 1.1×	21	326
Benjamin Y. Tan Singapore	10	73 0.4×	93 0.5×	36 0.3×	103 1.1×	38 0.6×	20	213

Countries citing papers authored by Jingming Ye

Since Specialization

Citations

This map shows the geographic impact of Jingming Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingming Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingming Ye more than expected).

Fields of papers citing papers by Jingming Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingming Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingming Ye. The network helps show where Jingming Ye may publish in the future.

Co-authorship network of co-authors of Jingming Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Jingming Ye. A scholar is included among the top collaborators of Jingming Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingming Ye. Jingming Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Jian, et al.. (2025). Sonographic Features of Juvenile Fibroadenoma in Children-a Retrospective Study. Current Medical Imaging Formerly Current Medical Imaging Reviews. 21. e15734056339987–e15734056339987.

Fu, Zhijian, Xiaojuan Zhu, Hongfeng Li, et al.. (2025). Metabolic characterization and radiomics-based composite model for breast cancer immune microenvironment types using 18F-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4511–4524.

Shen, Aomei, Hongmei Zhao, Jingming Ye, et al.. (2024). Preoperative inter-arm differences and normative-based thresholds for lymphedema in Chinese breast cancer patients: Insights from a large cohort study. Asia-Pacific Journal of Oncology Nursing. 11(10). 100567–100567.

Zhang, Xiumei, et al.. (2024). To diagnose primary and secondary squamous cell carcinoma of the thyroid with ultrasound malignancy risk stratification. Frontiers in Endocrinology. 14. 1238775–1238775.

Shen, Aomei, Jingming Ye, Hongmei Zhao, et al.. (2024). Risk factors and prediction model of breast cancer-related lymphoedema in a Chinese cancer centre: a prospective cohort study protocol. BMJ Open. 14(12). e089769–e089769.

Yin, Lei, Linlin Ma, Caixia Wu, et al.. (2024). Comparative analysis of metabolic characteristics and prognostic stratification of HER2-low and HER2-zero breast cancer using 18F-FDG PET/CT imaging. Cancer Imaging. 24(1). 166–166. 3 indexed citations

Liu, Hongjin, et al.. (2024). Integrative analysis identifies cancer cell-intrinsic RARRES1 as a predictor of prognosis and immune response in triple-negative breast cancer. Frontiers in Genetics. 15. 1360507–1360507. 1 indexed citations

Ding, Mao, et al.. (2023). Comparison of adverse effects of anti-tumor therapy for breast cancer shortly after COVID-19 diagnosis vs. the control period. Frontiers in Oncology. 13. 1203119–1203119. 1 indexed citations

Liu, Yinhua, et al.. (2023). Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer. Journal of Cancer Research and Clinical Oncology. 149(13). 12333–12353. 3 indexed citations

10.

He, Wei, et al.. (2022). Regulation of piglet T-cell immune responses by thioredoxin peroxidase from Cysticercus cellulosae excretory-secretory antigens. Frontiers in Microbiology. 13. 1019810–1019810. 5 indexed citations

11.

Liu, Yinhua, Yuan Jiang, Yi Liu, et al.. (2021). Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy. European Journal of Radiology. 146. 110095–110095. 32 indexed citations

12.

Liu, Hongjin, Liyuan Liu, Xiaoxi Chen, et al.. (2021). The detection rate of methylene blue combined with another tracer in sentinel lymph node biopsy of early-stage breast cancer: a systematic review and network meta-analysis. Translational Cancer Research. 10(12). 5222–5237. 7 indexed citations

13.

Liu, Qian, Hong Zhang, Shuang Zhang, et al.. (2020). Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing. Chinese Journal of Cancer Research. 32(2). 163–174. 2 indexed citations

14.

Ye, Jingming, Wenjun Wang, Ling Xu, et al.. (2017). A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer. Chinese Journal of Cancer Research. 29(4). 351–360. 26 indexed citations

15.

Zhou, Bin, Ling Xu, Jingming Ye, et al.. (2017). The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2- Enriched Subtype Breast Cancer, a Retrospective Analysis. Anticancer Research. 37(8). 4615–4621. 24 indexed citations

16.

Zhang, Hong, Shuang Zhang, Qian Liu, et al.. (2015). [Analysis on clinical and pathological characteristics of 66 patients with stage IV breast cancer].. PubMed. 53(12). 935–40. 2 indexed citations

17.

Liu, Shiwei, Xuening Duan, Ling Xu, et al.. (2015). Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 154(2). 239–249. 29 indexed citations

18.

Liu, Shiwei, Xuening Duan, Ling Xu, et al.. (2015). Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy. Tumor Biology. 37(4). 4873–4881. 10 indexed citations

19.

Zhang, Chi, Xuening Duan, Ling Xu, et al.. (2012). Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells. Breast Cancer Research and Treatment. 136(3). 739–748. 14 indexed citations

20.

Wang, Yunhong, Xiaoqi Qin, Hong Zhang, et al.. (2009). [Effect of neoadjuvant chemotherapy on histologic grade and expression of biological markers in breast cancer].. PubMed. 31(11). 858–62. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact